The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use
Authors:
- Daniel J. van WamelenDaniel J. van Wamelen
- Pablo Martinez‐MartinPMPablo Martinez‐Martin
- Angelo AntoniniAAAngelo Antonini
- Per OdinPOPer Odin
- Kallol Ray ChaudhuriKallol Ray Chaudhuri
- International Parkinson and Movement Disorder Society Parkinson's Disease Non‐Motor Study GroupIGInternational Parkinson and Movement Disorder Society Parkinson's Disease Non‐Motor Study Group
Open Access
- 19 August 2020
- journal article
- review article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 143 (1) , 3-12
Abstract
The Non‐Motor Symptoms Scale (NMSS) was developed and validated in 2007 as the first instrument for the comprehensive assessment of a range of non‐motor symptoms in Parkinson's disease (PD). Thirteen years have elapsed since its introduction and extensive international validation with good psychometric attributes has been carried out. Here, we review the validation data of the NMSS and its cross‐validity with other scales, and describe the key evidence derived from use of the NMSS in clinical studies. To date, over 100 clinical studies and trials have made use of it as an outcome measure, showing consistent and strong correlations between NMSS burden and health‐related quality of life measures. Moreover, the scale has shown to be capable of detecting longitudinal changes in non‐motor symptoms, where studies have shown differential changes over time of several of the NMSS domains. The scale has become a key outcome in several randomised clinical trials. Highlighting the prevalence and importance of non‐motor symptoms to quality of life in patients with PD, the development of NMSS has also been useful in signposting clinical and biomarker based research addressing non‐motor symptoms in PD.Keywords
This publication has 37 references indexed in Scilit:
- Disease duration-related differences in non-motor symptoms: A study of 616 Chinese Parkinson's disease patientsJournal of the Neurological Sciences, 2013
- A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet NeedPLOS ONE, 2013
- Independent validation of the Non motor Symptoms Scale for Parkinson's disease in Brazilian patientsParkinsonism & Related Disorders, 2013
- Validation of the Korean-Version of the Nonmotor Symptoms Scale for Parkinson's DiseaseJournal of Clinical Neurology, 2012
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)Movement Disorders, 2010
- The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaireMovement Disorders, 2010
- International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson diseaseNeurology, 2009
- Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of lifeMovement Disorders, 2009
- Quantitation of non‐motor symptoms in Parkinson’s diseaseEuropean Journal of Neurology, 2008
- The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot studyMovement Disorders, 2007